NEW ENGLAND CORD BLOOD BANK
New England Cord Blood Bank was founded in 1971 and is considered one of the pioneers in processing and cryopreservation of human cells and tissue. Our goal is to continue to be a premiere worldwide leader in cryopreservation of human cells, tissue, and cellular therapies. In addition, we aim to educate the public and medical communities on the availability of cryogenic storage of cells and tissue, along with their current and potential benefits for future use in treating disease and injury.
What Is Umbilical Cord Blood Used For?
Cord blood is unique in that it offers a quick, painless, controversy-free way of obtaining HSCs. Cord blood stem cells offer a number of advantages over bone marrow stem cells for donors and transplant recipients. It is much easier to collect, often more likely to provide a suitable match than bone marrow stem cells, and stored frozen so it is ready to use. Whereas a bone marrow transplant requires a patient-donor match of 6 out of 6 (or 100%), studies find that cord blood transplants are just as successful with a patient-donor match of 4 out of 6 (or 67%). Cord blood stem cells are currently used to treat patients with immune system and blood diseases including leukemia and lymphoma.
The importance of umbilical cord stem cells
The birth of a child represents a unique opportunity to safely and easily access two different types of these powerful cells. The umbilical cord contains hematopoietic stem cells (HSCs), or cord blood stem cells, and also mesenchymal stem cells (MSCs), in this case known as cord tissue stem cells.
Regenerative medicine is poised to play a vital role in the future of medical therapy, and at the heart of that revolution are stem cells. These special cells have great potential for therapies of the future and are currently approved for use in treatment for over eighty diseases.
Possible Treatment Benefits of Cord Blood and Tissue Banking
- Acute Biphenotypic Leukemia
- Acute Lymphocytic Leukemia (ALL)
- Acute Myelogenous Leukemia (AML)
- Acute Undifferentiated Leukemia
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Juvenile Chronic Myelogenous Leukemia (JCML)
- JuvenileMyelomonocytic Leukemia (JMML)
- Non-Hodgkin’s Lymphoma
- Prolymphocytic Leukemia
- Multiple Myeloma
- Acute Myelofibrosis
- Agnogenic Myeloid Metaplasia (Myelofibrosis)
- Aplastic Anemia (Severe)
- Essential Thrombocythemia
- Fanconi Anemia
- Myelodysplastic Syndrome
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Polycythemia Vera
- Pure Red Cell Aplasia
- Refractory Anemia with Excess Blasts (RAEB)
- Refractory Anemia with Excess Blasts in Transition (RAEB-T)
- Refractory Anemia with Ringed Sideroblasts (RARS)
- Sickle Cell Disease
- DiGeorge Syndrome
- Severe Combined Immunodeficiency Diseases (SCID)
- Kostmann Syndrome (SCID)
- Omenn Syndrome (SCID)
- Gaucher Disease
- Hunter Syndrome (MPS-II)
- Hurler Syndrome (MPS-IH)
- Krabbe Disease
- Maroteaux-Lamy Syndrome (MPS-VI)
- Metachromatic Leukodystrophy
- Mucolipidosis II (I-cell Disease)
- Niemann-Pick Disease
- Sanfilippo Syndrome (MPS-III)
- Scheie Syndrome (MPS-IS)
- Sly Syndrome (MPS-VII)
- Wolman Disease
Click on the image to download the brochure in PDF.